🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hangzhou
Clinical trial register · China

Clinical Trials in Hangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Hangzhou 38 Hanzhou 6 Zhengzhou 3 Changsha 2 Guangzhou 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine373 Zhejiang University104 First Affiliated Hospital of Zhejiang University103 AstraZeneca76 Zhejiang Cancer Hospital63 Clear sponsor filter
Site location
Hangzhou38 Hanzhou6 Zhengzhou3 Changsha2 Guangzhou2
All 24 locations
Target enrolment
to

Trials with a site in Hangzhou

38 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
NCT07751003COPD (Chronic Obstructive Pulmonary Disease), Acute Exacerbation of COPD, Hypercapnia
Sir Run Run Shaw Hospital
Not applicable
236
Zhengzhou, Changsha, Hangzhou, Wenling
2027-08-01
Recruiting
Electroacupuncture at ST36 for Reducing Postoperative Inflammation After Cardiac Surgery With Cardiopulmonary Bypass
NCT07795112Systemic Inflammatory Response Syndrome (SIRS), Cardiac Surgical Procedures, Postoperative Complications (Cardiopulmonary)
Sir Run Run Shaw Hospital
Not applicable
140
Hangzhou
2026-09-01
Not yet open
PTSD Risk Prediction Model for EICU Survivors
NCT07747415Post-traumatic Stress Disorder (PTSD)
Sir Run Run Shaw Hospital
Observational
800
Hangzhou
2026-08-15
Not yet open
Application of Multimodal Intervention in the Prevention of Postoperative Nausea and Vomiting After Gynecological Laparoscopic Surgery
NCT07631910Nausea and Vomiting, Postoperative
Sir Run Run Shaw Hospital
Not applicable
212
Hangzhou
2026-07-01
Recruiting
Transcutaneous Electrical Acustimulation on Postoperative Bowel Function Recovery in Elderly Patients
NCT07574502Colorectal Cancer (CRC)
Sir Run Run Shaw Hospital
Not applicable
190
Binzhou, Hangzhou
2026-06-14
Not yet open
Cognitive Behavioral Therapy for Mobile Phone Addiction in Hospitalized Patients
NCT07457658Problematic Use of Mobile Phones
Sir Run Run Shaw Hospital
Not applicable
140
Hangzhou
2026-06
By invitation
Left Atrial Appendage Closure With Versus Without Pulsed Field Ablation in Atrial Fibrillation Patients With Mild Symptoms and High Stroke Risk
NCT07453940ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, PFA Ablation and LAAC Procedures
Sir Run Run Shaw Hospital
Not applicable
50
Hangzhou
2026-05-07
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Preventing Acute Kidney Injury in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
NCT07549243Acute Kidney Injury, Cardiac Surgery, Cardiopulmonary Bypass
Sir Run Run Shaw Hospital
Not applicable
152
Hangzhou
2026-04-27
Active, closed
Home Oscillatory Positive Expiratory Pressure - Aerobic Exercise Rehabilitation Study
NCT06970054COPD, AECOPD
Sir Run Run Shaw Hospital
Not applicable
312
Hangzhou
2026-03-20
Not yet open
Decision-making and Optimization of Ventilatory Support for AECOPD Patients
NCT07508943Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Sir Run Run Shaw Hospital
Observational
1,000
Hangzhou
2026-03-18
Recruiting
Group-based IMPROVE Therapy for Problematic Internet Use in University Students
NCT07434778Problematic Internet Use
Sir Run Run Shaw Hospital
Not applicable
600
Hangzhou
2026-03-17
Active, closed
Modified Short-Course Radiotherapy Combined With Immunochemotherapy and Targeted Therapy as First-Line Treatment for MSS Metastatic Colorectal Cancer
NCT07512674Patients With Initially Unresectable MSS-type Advanced Colorectal Cancer With Liver and/or Lung and Peritoneal Metastasis
Sir Run Run Shaw Hospital
Phase 2
33
Hangzhou
2026-02-26
Active, closed
AI-Powered Sound Analysis for COPD Screening
NCT07457073Chronic Obstructive Pulmonary Disease (COPD)
Sir Run Run Shaw Hospital
Observational
3,000
Hangzhou
2026-02-23
Recruiting
Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule
NCT07508618Persistent Atrial Fibrillation
Sir Run Run Shaw Hospital
Phase 4
846
Hangzhou, Huzhou, Ningbo
2026-02-09
Not yet open
Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07393477Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma HNSCC
Sir Run Run Shaw Hospital
Phase 2
30
Hangzhou
2026-02
Recruiting
Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE
NCT07268560Complicated Intra-Abdominal Infections, cIAIs, Hospital-acquired Pneumonia (HAP), Ventilator-Associated Pneumonia (VAP)
Sir Run Run Shaw Hospital
Observational
100
Nanchang, Hangzhou
2025-12-25
Recruiting
Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma
NCT07243691Hepatocellular Carcinoma
Sir Run Run Shaw Hospital
Not applicable
33
Hangzhou
2025-12-01
Recruiting
Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer
NCT07068763Rectal Cancer
Sir Run Run Shaw Hospital
Phase 2
52
Hangzhou
2025-10-09
Active, closed
Evaluation of the Safety and Efficacy of a Wideband Electric Pulse Tumor Ablation System for Malignant Pulmonary Nodules
NCT07638228Malignant Pulmonary Nodules, Lung Cancer
Sir Run Run Shaw Hospital
Not applicable
5
Hangzhou
2025-09-01
Active, closed
The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)
NCT07160647dMMR/MSI-H-type Rectal Adenocarcinoma
Sir Run Run Shaw Hospital
Phase 2
29
Hangzhou
2025-08-20
Recruiting
Exploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma
NCT07105852Cholangiocarcinoma
Sir Run Run Shaw Hospital
Phase 2
59
Hangzhou
2025-07-03
Recruiting
Effectiveness of DITM Versus IMT in COPD Patients
NCT06958666COPD (Chronic Obstructive Pulmonary Disease)
Sir Run Run Shaw Hospital
Not applicable
410
Hangzhou, Lishui, Taizhou
2025-06-30
Recruiting
Diaphragmatic Physiology Similarity Index May Titrate HFNC Flow Setting: A Prospective Observational Study
NCT06996665Respiratory Failure
Sir Run Run Shaw Hospital
Not applicable
100
Hangzhou
2025-06-01
Recruiting
Early Endovascular Treatment in Isolated Internal Carotid Artery Occlusion
NCT07016854Stroke, Acute Ischemic
Sir Run Run Shaw Hospital
Not applicable
140
Hangzhou
2025-06
By invitation
Catheter Ablation for Atrial Fibrillation in Non-Fluoroscopic Lab
NCT06719921Atrial Fibrillation (AF)
Sir Run Run Shaw Hospital
Not applicable
724
Hangzhou
2025-04-22
Not yet open
Short-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer
NCT06872606Rectal Adenocarcinoma
Sir Run Run Shaw Hospital
Phase 2
33
Hangzhou
2025-04-01
Recruiting
Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma
NCT06825546Advanced Pancreatic Ductal Adenocarcinoma
Sir Run Run Shaw Hospital
Phase 2
70
Guangzhou, Zhengzhou, Wuhan, Changsha, Hangzhou, Wenzhou
2025-04-01
Not yet open
Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC
NCT06699459Biliary Tract Carcinoma
Sir Run Run Shaw Hospital
Phase 2
76
Fuzhou, Guangzhou, Shanghai, Hangzhou
2024-11-14
Recruiting
Smoking Cessation Program With CBT and Mindfulness Audio Support: A Randomized Controlled Trial
NCT06901713Smoking Cessation; Tobacco Dependence
Sir Run Run Shaw Hospital
Not applicable
2,000
Hangzhou
2024-10-09
Not yet open
Evaluating the Benefits of Personalized Traditional Chinese Medicine in Postoperative Treatment for Locally Advanced Colorectal Cancer
NCT06596343Locally Advanced Colorectal Cancer, Postoperative Adjuvant Therapy
Sir Run Run Shaw Hospital
Phase 2
80
Hangzhou
2024-10
Not yet open
Node-Sparing Short-Course Radiation With CAPOX and Sintilimab for MSS Locally Advanced Colon Cancer: A Randomized, Prospective, Multicenter Study
NCT06594692Microsatellite Stable (MSS) Colon Cancer, Locally Advanced Colon Cancer
Sir Run Run Shaw Hospital
Phase 2
140
Hangzhou
2024-10
Recruiting
The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma
NCT06266832Rectal Adenocarcinoma
Sir Run Run Shaw Hospital
Phase 2
30
Hangzhou
2024-01-01
Recruiting
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms
NCT06026800Digestive System Neoplasms
Sir Run Run Shaw Hospital
Phase 1
20
Hangzhou
2023-09-08
Recruiting
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms
NCT06026774Digestive System Neoplasms
Sir Run Run Shaw Hospital
Phase 1
20
Hangzhou
2023-09-08
Recruiting
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms
NCT06019702Digestive System Neoplasms
Sir Run Run Shaw Hospital
Phase 1
20
Hangzhou
2023-09-08
Recruiting
Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma
NCT05752136Rectal Cancer
Sir Run Run Shaw Hospital
Phase 3
108
Hangzhou
2023-04-01
Recruiting
Therapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion
NCT06633809Stroke, Acute, Cerebrovascular Disorders, Brain Diseases, Central Nervous System Diseases
Sir Run Run Shaw Hospital
Observational
200
Hangzhou
2021-11-22
Recruiting
The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy
NCT05035108Hepatoma Resectable
Sir Run Run Shaw Hospital
Phase EARLY_PHASE1
10
Hangzhou
2021-09-05
Rows per page Showing 1–38 of 38
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/hangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 38 of those studies with a site in Hangzhou that also match the filters currently applied.

How many clinical trials are recruiting in Hangzhou?

21 of the 38 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 10 have not yet opened recruitment, 5 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hangzhou), 38 studies
PhaseStudiesRecruitingShare
Not applicable16942.1%
Phase 211428.9%
Observational5213.2%
Phase 1337.9%
Phase 3112.6%
Phase 4112.6%
Phase EARLY_PHASE1112.6%

Most active sponsors

Lead sponsors with the most studies (Hangzhou)
Lead sponsorStudiesRecruiting
Sir Run Run Shaw Hospital3821
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.